Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Innoviva (INVA) Short-term Investments (2016 - 2022)

Historic Short-term Investments for Innoviva (INVA) over the last 13 years, with Q3 2022 value amounting to $282000.0.

  • Innoviva's Short-term Investments changed N/A to $282000.0 in Q3 2022 from the same period last year, while for Sep 2022 it was $282000.0, marking a year-over-year change of. This contributed to the annual value of $282000.0 for FY2022, which is N/A changed from last year.
  • Innoviva's Short-term Investments amounted to $282000.0 in Q3 2022.
  • Innoviva's Short-term Investments' 5-year high stood at $127.0 million during Q1 2019, with a 5-year trough of $282000.0 in Q3 2022.
  • Moreover, its 4-year median value for Short-term Investments was $32.0 million (2020), whereas its average is $52.5 million.
  • Per our database at Business Quant, Innoviva's Short-term Investments skyrocketed by 170997.82% in 2019 and then plummeted by 9628.73% in 2020.
  • Innoviva's Short-term Investments (Quarter) stood at $52.5 million in 2018, then skyrocketed by 38.59% to $72.7 million in 2019, then crashed by 94.5% to $4.0 million in 2020, then crashed by 92.95% to $282000.0 in 2022.
  • Its Short-term Investments stands at $282000.0 for Q3 2022, versus $4.0 million for Q2 2020 and $32.0 million for Q1 2020.